4:49 PM ET
8-K
Capital Raise
BioStem Technologies Capital Raise of $3M
BioStem Technologies entered into a securities purchase agreement with institutional investors for a $3.0 million private placement of 735,296 shares of common stock. The offering includes Series A and Series B warrants to purchase additional shares at an exercise price of $3.83 per share, which could provide an additional $5.6 million if fully exercised. Proceeds are intended for working capital and general corporate purposes.
- Value
- $3M
- Counterparty
- institutional investors